BPA Call 15B41423A00000036-15B41426F00000091
- Biopool U.S., Inc., operating as Trinity Biotech Distribution, was awarded a $11.7K firm fixed-price blanket purchase agreement (BPA) call on April 1, 2026, for the U.S. Medical Center for Federal Prisoners in Springfield, Missouri. The contract, which extends through June 30, 2026, covers the procurement of two hemoglobin A1c analyzers, including all associated clinical materials and required service support. This award was issued as a call against the General Services Administration's Critical...
- The U.S. Medical Center for Federal Prisoners in Springfield, Missouri awarded a $3,900 firm fixed price contract to Biopool U.S., Inc., doing business as Trinity Biotech Distribution, on January 1, 2026, with an ultimate completion date of January 31, 2026. This BPA call against the General Services Administration's Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) procures two hemoglobin A1c analyzers along with all necessary clinical materials and required service support....
- Biopool U.S., Inc., operating as Trinity Biotech Distribution, received a Firm Fixed Price BPA call modification totaling $48,129.74 against the General Services Administration's Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) to support the U.S. Medical Center for Federal Prisoners in Springfield, Missouri. The modification increases estimated funding for the FY25 period to cover invoices received during the applicable timeframe for two hemoglobin A1c analyzers and...
- This contract was awarded to Biopool US, Inc., a foreign-owned, for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment that does business as Trinity Biotech Distribution. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 on May 23, 2019 and has a potential value of $115,041.75. It is a BPA (Blanket Purchase Agreement) Call under the Critical Analyzers, Laboratory...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Biopool U.S., Inc., doing business as Trinity Biotech Distribution, for the provision of Hemoglobin A1C testing services at a cost per reportable result. The contract has a ceiling value of $34,000.00 and a period of performance from July 1, 2025 to June 30, 2026. Biopool U.S., Inc. is a foreign-owned, for-profit manufacturer of medical diagnostic products and laboratory...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Biopool US, Inc., a foreign-owned for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment doing business as Trinity Biotech Distribution. The $22,230.00 contract is for the provision of glycohemoglobin analyzers, which are critical laboratory analyzers used to support quality healthcare and medical readiness programs. Biopool US, Inc....
- This is a federal contract award to Biopool U.S., Inc., doing business as Trinity Biotech Distribution, for the provision of hemoglobin A1c testing services on a cost per reportable results (CPRR) basis. The contract, valued at a ceiling of $42,500.00, was awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) call, issued under the VA's Critical Analyzers, Laboratory Federal Supply...
- This is a federal contract award to Biopool U.S., Inc., doing business as Trinity Biotech Distribution, a foreign-owned, for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment based in Jamestown, New York. The $1,395.00 fixed-price delivery order contract with economic price adjustment is for the supply of "SYPH G EIA 1-PLATE" medical supplies. The contract is not set aside and is funded by the Department of Defense's Medical Supply Chain...
- This is a firm fixed price call order awarded by the U.S. Department of Veterans Affairs to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for glycated hemoglobin (HbA1c) clinical reference laboratory services. The call order has a ceiling value of $95,657.75 and an ultimate completion date of November 21, 2020. The contract was awarded without a set-aside on November 22, 2019 under the Critical Analyzers, Laboratory (FSS-66-III) GSA schedule. Biopool U.S., Inc. has provided various...
- This federal contract award was issued by the Department of Veterans Affairs to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for the provision of service lab reagents for glycohemoglobin testing. The contract, which has a ceiling value of $429,024.90, was awarded on a firm fixed price basis. It is a delivery order contract under the Critical Analyzers, Laboratory (FSS-66-III) master schedule. The contract does not have a set-aside designation. Through this award, Biopool U.S., Inc....
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797D40089-15B41423A00000036Blanket Purchase Agreement
- 15B41423A00000036-15B41426F00000091BPA Call
Biopool U.S., Inc., operating as Trinity Biotech Distribution, was awarded a $3,900 firm fixed-price blanket purchase agreement (BPA) call on February 1, 2026, by the U.S. Medical Center for Federal Prisoners in Springfield, Missouri. The contract covers the procurement of two hemoglobin A1c analyzers along with all associated clinical materials and required service support, with an ultimate completion date of April 9, 2026. This award is issued against the General Services Administration's Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) and represents a continuation of the vendor's ongoing laboratory diagnostics support to federal correctional healthcare operations. Biopool U.S., Inc., a subsidiary of Ireland-based Trinity Biotech PLC headquartered in Jamestown, New York, is a specialized manufacturer and distributor of clinical laboratory diagnostics equipment. The company has established a substantial federal presence with approximately $58.87 million in active indefinite delivery vehicle ceiling values across multiple agencies, including the Department of Veterans Affairs, Defense Logistics Agency, and the General Services Administration. The contract carries no set-aside designation, indicating full and open competition. This specific award supports the Medical Center's diabetes screening and management capabilities through provision of advanced hemoglobin A1c testing instrumentation and associated clinical support services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 4/8/26 |